Diabetes Type 2

Type 2 Diabetes Defines Your Everyday

There is an unmet need for new care options to manage and effectively control diabetes. Local physicians are currently conducting a clinical trial to evaluate a once-weekly injection of semaglutide added to dose-reduced insulin glargine versus insulin glargine titrated.

To be eligible you must:

  • Be at least 18 years old
  • Be diagnosed with diabetes (type 2)
  • Be currently treating diabetes with once daily insulin glargine injections

Those that qualify may:

  • Receive an investigational medication
  • See a physician or medical staff at no cost
  • Receive compensation for time and travel

No insurance is required to participate.

For more information, and to see if you qualify, please contact us today!
  • This field is for validation purposes and should be left unchanged.
Osteoarthritis
FREE Memory Evaluations
Menu